Rituxan Shows Sustained Benefit For RA In Phase II Trials
Rituxan has positive results in Phase II trial for RA. Nexium Reduces Risk Of Ulcers For Long-term NSAID Users
Stidy shows that a proton-pump inhibitor, Nexium, reduces the development of ulcers in regular users of NSAIDS. First Visit To The Rheumatologist
What to consider when preparing for your first appointment with a rheumatologist. Prexige Approved In United Kingdom
A COX-2 inhibitor being developed by Novartis was approved in the United Kingdom. Canada's Cheap Drugs: To Buy Or Not To Buy?
FDA warns about safety of purchasing prescription drugs from foreign countries. FDA Approves Stair-Climbing Wheelchair
FDA approves expensive wheelchair which gives wheelchair-bound patients the ability to climb stairs and elevate to standing position. Electrical Muscle Stimulation Helps Knee OA
NMES, neuromuscular electrical stimulation, can improve strength and physical function in people with osteoarthritis of the knee. Ankylosing Spondylitis: Often A Delayed Or Difficult Diagnosis
Ankylosing spondylitis can be a delayed or difficult diagnosis leading to poor quality of life. Canada: Will Sell Marijuana, Seeds For Medical Use
The long-running debate about medicinal marijuana was decided in Canada. As an interim measure, Canada will sell it to those medically eligible patients. Too Young For Joint Replacement?
Joint replacement is not always considered an option for young people with arthritis. However, new study results are positive. Vioxx Effective For Chronic Low Back Pain
Study resuls indicate that one of the COX-2 inhibitors approved for the treatment of arthritis is also safe and effective for chronic low back pain. Study Suggests Cause For Restless Legs Syndrome
Restless legs syndrome is an unusual affliction with as yet an unknown cause. Recent studies may have pinpointed the cause. Should You Change Doctors?
A doctor/patient relationship is a lifelong relationship for someone with a chronic illness. Are your needs being met or is it time to look for another doctor? Risk Of RA May Be Tied To Birth Weight
A new study in BMJ concludes that birth weight may be a factor in the risk of developing rheumatoid arthritis. ARTHRITIS FOUNDATION ENCOURAGES "MORE LIFE, LESS LIMITS"
The Arthritis Foundation kicks off National Arthritis Month encouraging the 70 million people with arthritis to seek more life and fewer limitations. Raptiva Drug Trial Halted
Development of Raptiva for rheumatoid arthritis has been stopped by Genentech and Xoma. NIAMS To Study Gabapentin For FMS
NIAMS will fund a study to measure effectiveness of gabapentin in reducing symptoms of fibromyalgia. Arthritis Drugs: What Are My Options?
Medications are among the most popular treatment options for people with arthritis. A knowledge of the various categories of arthritis drugs can help decide the best and most effective treatment. The Arthritis Walk: Kick-off to Arthritis Month
The Arthritis Foundation is hosting its annual Arthritis Walk across the country to raise funds. | 